• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2003年澳大利亚淋球菌监测项目年度报告

Annual report of the Australian Gonococcal Surveillance Programme, 2003.

出版信息

Commun Dis Intell Q Rep. 2004;28(2):187-93. doi: 10.33321/cdi.2004.28.16.

DOI:10.33321/cdi.2004.28.16
PMID:15460955
Abstract

The Australian Gonococcal Surveillance Programme monitors the antibiotic susceptibility of Neisseria gonorrhoeae isolated in all Australian states and territories. In 2003 the in vitro susceptibility of 3,772 isolates of gonococci from public and private sector sources was determined by standardised methods. Antibiotic susceptibility patterns again varied considerably between jurisdictions and regions. Resistance to the penicillins nationally, was 17 per cent but ranged up to 27 per cent in larger urban centres. Quinolone resistance in gonococci (QRNG) remained widespread and increased in most states but most markedly in Victoria. Nationally, 14.4 per cent of all isolates were QRNG, and most of this resistance was at high MIC levels. All isolates remained sensitive to spectinomycin. A small number of isolates showed some decreased susceptibility to ceftriaxone (MIC 0.06 mg/L or more) and were concentrated in New South Wales. A high proportion of gonococci examined in larger urban centres were from male patients and rectal and pharyngeal isolates were common. In other centres and in rural Australia the male to female ratio of cases was lower, and most isolates were from the genital tract. In New South Wales, the number of available cultures decreased and represented 30 per cent of the national total. In Victoria, the number of isolates increased and was 25 per cent of all gonococci examined.

摘要

澳大利亚淋病监测项目对在澳大利亚所有州和领地分离出的淋病奈瑟菌的抗生素敏感性进行监测。2003年,采用标准化方法测定了来自公共和私营部门的3772株淋病奈瑟菌的体外敏感性。不同司法管辖区和地区之间的抗生素敏感性模式再次存在很大差异。全国范围内对青霉素的耐药率为17%,但在较大的城市中心高达27%。淋病奈瑟菌喹诺酮耐药性(QRNG)仍然普遍存在,大多数州有所增加,但在维多利亚州最为明显。全国范围内,所有分离株中有14.4%为QRNG,且大多数耐药性处于高最低抑菌浓度水平。所有分离株对壮观霉素仍敏感。少数分离株对头孢曲松的敏感性有所下降(最低抑菌浓度为0.06mg/L或更高),且集中在新南威尔士州。在较大城市中心检测的淋病奈瑟菌中,很大一部分来自男性患者,直肠和咽部分离株很常见。在其他中心以及澳大利亚农村地区,病例的男女比例较低,且大多数分离株来自生殖道。在新南威尔士州,可用培养物数量减少,占全国总数的30%。在维多利亚州,分离株数量增加,占所有检测淋病奈瑟菌的25%。

相似文献

1
Annual report of the Australian Gonococcal Surveillance Programme, 2003.2003年澳大利亚淋球菌监测项目年度报告
Commun Dis Intell Q Rep. 2004;28(2):187-93. doi: 10.33321/cdi.2004.28.16.
2
Annual report of the Australian Gonococcal Surveillance Programme, 2000.《2000年澳大利亚淋球菌监测项目年度报告》
Commun Dis Intell Q Rep. 2001 Apr;25(2):59-63. doi: 10.33321/cdi.2001.25.12.
3
Annual report of the Australian Gonococcal Surveillance Programme, 2002.
Commun Dis Intell Q Rep. 2003;27(2):189-95. doi: 10.33321/cdi.2003.27.43.
4
Annual report of the Australian Gonococcal Surveillance Programme, 2004.《2004年澳大利亚淋球菌监测项目年度报告》
Commun Dis Intell Q Rep. 2005;29(2):137-42. doi: 10.33321/cdi.2005.29.12.
5
Annual report of the Australian Gonococcal Surveillance Programme, 2001.《2001年澳大利亚淋球菌监测项目年度报告》
Commun Dis Intell Q Rep. 2002;26(2):242-7. doi: 10.33321/cdi.2002.26.20.
6
Annual report of the Australian Gonococcal Surveillance Programme, 2007.2007年澳大利亚淋球菌监测项目年度报告
Commun Dis Intell Q Rep. 2008 Jun;32(2):227-31. doi: 10.33321/cdi.2008.32.20.
7
Annual report of the Australian Gonococcal Surveillance Programme, 2005.《2005年澳大利亚淋球菌监测项目年度报告》
Commun Dis Intell Q Rep. 2006;30(2):205-10. doi: 10.33321/cdi.2006.30.16.
8
Annual report of the Australian Gonococcal Surveillance Programme, 2011.2011年澳大利亚淋球菌监测项目年度报告
Commun Dis Intell Q Rep. 2012 Jun 30;36(2):E166-73. doi: 10.33321/cdi.2012.36.11.
9
Annual report of the Australian Gonococcal Surveillance Programme, 2006.2006年澳大利亚淋球菌监测项目年度报告
Commun Dis Intell Q Rep. 2007 Jun;31(2):180-4. doi: 10.33321/cdi.2007.31.13.
10
Annual Report of the Australian Gonococcal Surveillance Programme, 2009.《2009年澳大利亚淋球菌监测项目年度报告》
Commun Dis Intell Q Rep. 2010 Jun;34(2):89-95. doi: 10.33321/cdi.2010.34.12.

引用本文的文献

1
Policy, practice, and prediction: model-based approaches to evaluating N. gonorrhoeae antibiotic susceptibility test uptake in Australia.政策、实践与预测:基于模型的方法评估澳大利亚淋病奈瑟菌抗生素药敏试验采用率
BMC Infect Dis. 2024 May 17;24(1):498. doi: 10.1186/s12879-024-09393-y.
2
Trends in Antimicrobial Resistance Patterns in Neisseria Gonorrhoeae in Australia and New Zealand: A Meta-analysis and Systematic Review.澳大利亚和新西兰淋病奈瑟菌抗菌药物耐药模式的趋势:一项荟萃分析和系统评价
Antibiotics (Basel). 2019 Oct 23;8(4):191. doi: 10.3390/antibiotics8040191.